Search research articles
Contact Us
Filters
Showing results (31-40 of 110) with videos related to
Page
of 11
Sort By:
Frontiers in Oncology
|
August 28, 2020
Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality
Xiaohan Zhou, Wanting Hou, Ling Gao, et al.
Foods (Basel, Switzerland)
|
March 13, 2025
Dynamic Changes in Physicochemical Properties and Microbial Diversity During the Fermentation of Mao-Tofu
Dongqi Li, Yaqiong Wan, Xiaohan Zhou, et al.
Frontiers in Immunology
|
July 26, 2021
A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint
Xiaohan Zhou, Jun Du, Chengdong Liu, et al.
Asian Journal of Pharmaceutical Sciences
|
March 17, 2020
Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
Xiaohan Zhou, Kun Shi, Ying Hao, et al.
Annals of Palliative Medicine
|
August 6, 2021
Intermittent tube feeding for stroke patients with dysphagia: a meta-analysis and systematic review
Chao Wu, Xuefang Zhu, Xiaohan Zhou, et al.
The Science of the Total Environment
|
October 18, 2022
Combined removal of SO<sub>3</sub> and HCl by modified Ca(OH)<sub>2</sub> from coal-fired flue gas
Xiaohan Zhou, Wenjing Tang, Minqiang He, et al.
Aob PLANTS
|
February 8, 2023
Machine learning versus crop growth models: an ally, not a rival
Ningyi Zhang, Xiaohan Zhou, Mengzhen Kang, et al.
Journal of Cancer Research and Clinical Oncology
|
March 16, 2021
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials
Wanting Hou, Mingfu Ding, Xiaohua Li, et al.
The Journal of Physical Chemistry. B
|
April 29, 2024
Diffusion and Oligomerization States of the Muscarinic M<sub>1</sub> Receptor in Live Cells─The Impact of Ligands and Membrane Disruptors
Xiaohan Zhou, Horacio Septien-Gonzalez, Sami Husaini, et al.
BMC Cancer
|
July 11, 2020
Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma
Lin Shui, Ke Cheng, Xiaofen Li, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 110) with videos related to
Sort By:
Page
of 11
Frontiers in Oncology
|
August 28, 2020
Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality
Xiaohan Zhou, Wanting Hou, Ling Gao, et al.
Foods (Basel, Switzerland)
|
March 13, 2025
Dynamic Changes in Physicochemical Properties and Microbial Diversity During the Fermentation of Mao-Tofu
Dongqi Li, Yaqiong Wan, Xiaohan Zhou, et al.
Frontiers in Immunology
|
July 26, 2021
A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint
Xiaohan Zhou, Jun Du, Chengdong Liu, et al.
Asian Journal of Pharmaceutical Sciences
|
March 17, 2020
Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
Xiaohan Zhou, Kun Shi, Ying Hao, et al.
Annals of Palliative Medicine
|
August 6, 2021
Intermittent tube feeding for stroke patients with dysphagia: a meta-analysis and systematic review
Chao Wu, Xuefang Zhu, Xiaohan Zhou, et al.
The Science of the Total Environment
|
October 18, 2022
Combined removal of SO<sub>3</sub> and HCl by modified Ca(OH)<sub>2</sub> from coal-fired flue gas
Xiaohan Zhou, Wenjing Tang, Minqiang He, et al.
Aob PLANTS
|
February 8, 2023
Machine learning versus crop growth models: an ally, not a rival
Ningyi Zhang, Xiaohan Zhou, Mengzhen Kang, et al.
Journal of Cancer Research and Clinical Oncology
|
March 16, 2021
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials
Wanting Hou, Mingfu Ding, Xiaohua Li, et al.
The Journal of Physical Chemistry. B
|
April 29, 2024
Diffusion and Oligomerization States of the Muscarinic M<sub>1</sub> Receptor in Live Cells─The Impact of Ligands and Membrane Disruptors
Xiaohan Zhou, Horacio Septien-Gonzalez, Sami Husaini, et al.
BMC Cancer
|
July 11, 2020
Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma
Lin Shui, Ke Cheng, Xiaofen Li, et al.
Page
of 11